Please login to the form below

Not currently logged in
Email:
Password:

chronic spontaneous urticaria

This page shows the latest chronic spontaneous urticaria news and features for those working in and with pharma, biotech and healthcare.

Novartis reveals positive efficacy data for Xolair follow-up

Novartis reveals positive efficacy data for Xolair follow-up

The new treatment is being studied in chronic spontaneous urticaria (CSU), one of Xolair’s  approved indications.

Latest news

More from news
Approximately 4 fully matching, plus 6 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics